Godavari Biorefineries Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹1,043 Cr
- P/E
- 35.96
- ROE
- 4.08%
- PEG
- 2.18
- Price to sales
- 0.51
- Debt to equity
- 0.67
- 52W high / low
- ₹335 / ₹197
- Sales growth (5Y)
- 5.26%
- EBITDA margin
- 6.06%
- Net profit margin
- 1.61%
- Promoter holding
- 63.31%
- Sales (last year)
- ₹2,013 Cr
Guidance scorecard · Q1 FY27 call
What Godavari Biorefineries Ltd's management guided
RevenueQ1 FY27 call
10–20%- Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28.
- Operating cash flows in the chemical sector expected to improve and sustain due to better gross margins and debottlenecking benefits.
- Ethanol demand anticipated to grow with E20 rollout continuing and introduction of E85 and E100 fuels, supported by government policies and flex-fuel vehicles.
- Investing in additional maize/grain front-end capacity to optimize product mix and improve ethanol production flexibility.
2 more points from Godavari Biorefineries Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Down 0–2%See what Godavari Biorefineries Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
- Exploring front-end investments in maize/grain preparation facilities to utilize idle fermentation and distillation capacity, potentially adding 160 KLPD fungible capacity within the existing 800 KLPD distillery.
- Committed to spending INR 20 crores over the next 30-33 months on drug discovery, including safety trials for a novel anticancer molecule.
2 more points from Godavari Biorefineries Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
None plannedSee what Godavari Biorefineries Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- The company is experiencing strong and growing demand in its bio-based specialty chemicals business both domestically and internationally.
- They are expecting sales of about INR 190 crores in the current quarter, up from INR 169 crores reported last quarter.
- Post completion of a planned INR 25 crore debottlenecking investment (expected by the start of FY28), they anticipate bio-based specialty chemicals business to reach around INR 240 crores per quarter.
- There is significant customer interest fueled by global supply tightness and increased focus on supply chain reliability.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Godavari Biorefineries Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Godavari Biorefineries Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 239 | 398 | 615 | 523 | 321 | 447 | 580 | 533 | 431 | 460 | 564 |
| Expenses + | 271 | 353 | 501 | 535 | 354 | 411 | 467 | 527 | 439 | 417 | 478 |
| Operating Profit | -32 | 45 | 114 | -12 | -33 | 36 | 112 | 6 | -8 | 43 | 86 |
| OPM % | -13% | 11% | 18% | -2% | -10% | 8% | 19% | 1% | -2% | 9% | 15% |
| Other Income + | 1 | 2 | 11 | 3 | 1 | 4 | 9 | 1 | -23 | -6 | 9 |
| Interest | 20 | 18 | 20 | 20 | 20 | 19 | 13 | 15 | 12 | 10 | 11 |
| Depreciation | 15 | 16 | 14 | 13 | 12 | 12 | 13 | 14 | 14 | 14 | 14 |
| Profit before tax | -65 | 13 | 91 | -42 | -64 | 8 | 96 | -22 | -57 | 13 | 70 |
| Tax % | 0% | -201% | 28% | -37% | 17% | 32% | 25% | -28% | -27% | 39% | 25% |
| Net Profit + | -65 | 38 | 65 | -26 | -75 | 6 | 72 | -16 | -42 | 8 | 53 |
| EPS in Rs | -15.53 | 9.16 | 15.54 | -6.23 | -17.88 | 1.13 | 14.06 | -3.13 | -8.13 | 1.61 | 10.33 |
Financials of Godavari Biorefineries Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 1,459 | 1,538 | 1,702 | 2,015 | 1,687 | 1,870 | 1,988 |
| Expenses + | 1,356 | 1,381 | 1,568 | 1,867 | 1,553 | 1,766 | 1,861 |
| Operating Profit | 103 | 158 | 134 | 147 | 134 | 104 | 127 |
| OPM % | 7% | 10% | 8% | 7% | 8% | 6% | 6% |
| Other Income + | 14 | 8 | 6 | 7 | 14 | 16 | -19 |
| Interest | 69 | 72 | 60 | 73 | 76 | 72 | 49 |
| Depreciation | 45 | 47 | 48 | 50 | 60 | 50 | 54 |
| Profit before tax | 3 | 46 | 32 | 32 | 12 | -2 | 5 |
| Tax % | -24% | 41% | 40% | 38% | 1% | 1,421% | 23% |
| Net Profit + | 4 | 27 | 19 | 20 | 12 | -23 | 4 |
| EPS in Rs | 0.97 | 6.47 | 4.55 | 4.68 | 2.93 | -4.57 | 0.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Godavari Biorefineries Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 | 51 |
| Reserves | 385 | 412 | 431 | 448 | 459 | 731 | 737 |
| Borrowings + | 589 | 569 | 636 | 736 | 655 | 490 | 531 |
| Other Liabilities + | 418 | 419 | 625 | 518 | 836 | 683 | 733 |
| Total Liabilities | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 |
| Fixed Assets + | 735 | 708 | 667 | 866 | 850 | 862 | 885 |
| CWIP | 17 | 9 | 50 | 17 | 29 | 37 | 129 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 683 | 725 | 1,016 | 860 | 1,113 | 1,055 | 1,038 |
| Total Assets | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 |
Financials of Godavari Biorefineries Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 250 | 130 | 45 | 197 | 185 | 6 | 171 |
| Cash from Investing Activity + | -23 | -7 | -48 | -214 | -44 | -69 | -163 |
| Cash from Financing Activity + | -226 | -121 | 6 | 28 | -151 | 64 | -6 |
| Net Cash Flow | 1 | 2 | 3 | 11 | -10 | 1 | 3 |
| Free Cash Flow | 223 | 119 | -5 | -20 | 130 | -65 | 6 |
| CFO/OP | 242% | 82% | 34% | 135% | 140% | 6% | 136% |
Financials of Godavari Biorefineries Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31 | 40 | 37 | 37 | 41 | 27 | 21 |
| Inventory Days | 130 | 146 | 200 | 137 | 250 | 195 | 198 |
| Days Payable | 123 | 132 | 176 | 105 | 195 | 140 | 146 |
| Cash Conversion Cycle | 39 | 55 | 61 | 68 | 95 | 82 | 74 |
| Working Capital Days | -68 | 1 | 3 | 2 | -14 | 21 | 16 |
| ROCE % | 12% | 9% | 9% | 7% | 6% | 7% |
Guidance history
How Godavari Biorefineries Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Down 0–2% | Planned | None planned | — |
| Q4 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q3 FY26 call → | 10–20% | Up 2%+ | Planned | — | — |
| Q2 FY26 call → | 10–20% | Up 2%+ | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
9 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −24.4% | 33% |
| Last 6 months | −35.9% | 5% |
| Last 3 months | −21.8% | 17% |
The price is 47.7% below its all-time high of ₹390.2 (6 Dec 2024). Stocks more than 20% below their peak have their score halved, so 18 became 9.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Godavari Biorefineries Ltd: 0.4 × 33 + 0.4 × 5 + 0.2 × 17 = 18, halved to 9 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.